Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma

Renal cell carcinoma (RCC) is the most common type of kidney cancer with rising cases in recent years. Extensive research has identified various cancer driver proteins associated with different subtypes of RCC. Most RCC drivers are encoded by tumor suppressor genes and exhibit enrichment in function...

Full description

Bibliographic Details
Main Authors: Jimin Pei, Jing Zhang, Qian Cong
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.13732
_version_ 1797367589828034560
author Jimin Pei
Jing Zhang
Qian Cong
author_facet Jimin Pei
Jing Zhang
Qian Cong
author_sort Jimin Pei
collection DOAJ
description Renal cell carcinoma (RCC) is the most common type of kidney cancer with rising cases in recent years. Extensive research has identified various cancer driver proteins associated with different subtypes of RCC. Most RCC drivers are encoded by tumor suppressor genes and exhibit enrichment in functional categories such as protein degradation, chromatin remodeling, and transcription. To further our understanding of RCC, we utilized powerful deep‐learning methods based on AlphaFold to predict protein–protein interactions (PPIs) involving RCC drivers. We predicted high‐confidence complexes formed by various RCC drivers, including TCEB1, KMT2C/D and KDM6A of the COMPASS‐related complexes, TSC1 of the MTOR pathway, and TRRAP. These predictions provide valuable structural insights into the interaction interfaces, some of which are promising targets for cancer drug design, such as the NRF2‐MAFK interface. Cancer somatic missense mutations from large datasets of genome sequencing of RCCs were mapped to the interfaces of predicted and experimental structures of PPIs involving RCC drivers, and their effects on the binding affinity were evaluated. We observed more than 100 cancer somatic mutations affecting the binding affinity of complexes formed by key RCC drivers such as VHL and TCEB1. These findings emphasize the importance of these mutations in RCC pathogenesis and potentially offer new avenues for targeted therapies.
first_indexed 2024-03-08T17:20:32Z
format Article
id doaj.art-22df5761c5ea4f968f76fc547471fb31
institution Directory Open Access Journal
issn 2211-5463
language English
last_indexed 2024-03-08T17:20:32Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj.art-22df5761c5ea4f968f76fc547471fb312024-01-03T05:28:43ZengWileyFEBS Open Bio2211-54632024-01-0114111212610.1002/2211-5463.13732Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinomaJimin Pei0Jing Zhang1Qian Cong2Eugene McDermott Center for Human Growth and Development University of Texas Southwestern Medical Center Dallas TX USAEugene McDermott Center for Human Growth and Development University of Texas Southwestern Medical Center Dallas TX USAEugene McDermott Center for Human Growth and Development University of Texas Southwestern Medical Center Dallas TX USARenal cell carcinoma (RCC) is the most common type of kidney cancer with rising cases in recent years. Extensive research has identified various cancer driver proteins associated with different subtypes of RCC. Most RCC drivers are encoded by tumor suppressor genes and exhibit enrichment in functional categories such as protein degradation, chromatin remodeling, and transcription. To further our understanding of RCC, we utilized powerful deep‐learning methods based on AlphaFold to predict protein–protein interactions (PPIs) involving RCC drivers. We predicted high‐confidence complexes formed by various RCC drivers, including TCEB1, KMT2C/D and KDM6A of the COMPASS‐related complexes, TSC1 of the MTOR pathway, and TRRAP. These predictions provide valuable structural insights into the interaction interfaces, some of which are promising targets for cancer drug design, such as the NRF2‐MAFK interface. Cancer somatic missense mutations from large datasets of genome sequencing of RCCs were mapped to the interfaces of predicted and experimental structures of PPIs involving RCC drivers, and their effects on the binding affinity were evaluated. We observed more than 100 cancer somatic mutations affecting the binding affinity of complexes formed by key RCC drivers such as VHL and TCEB1. These findings emphasize the importance of these mutations in RCC pathogenesis and potentially offer new avenues for targeted therapies.https://doi.org/10.1002/2211-5463.13732cancer driverschromatin remodelingprotein–protein interactionrenal cell carcinomaubiquitination
spellingShingle Jimin Pei
Jing Zhang
Qian Cong
Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
FEBS Open Bio
cancer drivers
chromatin remodeling
protein–protein interaction
renal cell carcinoma
ubiquitination
title Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
title_full Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
title_fullStr Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
title_full_unstemmed Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
title_short Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
title_sort computational analysis of protein protein interactions of cancer drivers in renal cell carcinoma
topic cancer drivers
chromatin remodeling
protein–protein interaction
renal cell carcinoma
ubiquitination
url https://doi.org/10.1002/2211-5463.13732
work_keys_str_mv AT jiminpei computationalanalysisofproteinproteininteractionsofcancerdriversinrenalcellcarcinoma
AT jingzhang computationalanalysisofproteinproteininteractionsofcancerdriversinrenalcellcarcinoma
AT qiancong computationalanalysisofproteinproteininteractionsofcancerdriversinrenalcellcarcinoma